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Going first: the ethics of vaccine
self-experimentation in coronavirus times
Manríquez Roa Tania, Biller-Andorno Nikola
Institute of Biomedical Ethics and History of Medicine, University of Zurich
In the context of the COVID-19 pandemic, a number of
scientists have been conducting experiments on them-
selves voluntarily and deliberately, with the goal of finding
a vaccine against the virus. This practice is not new. In
the past, scientists and physicians embarked on self-exper-
imentation to develop polio, typhoid and rabies vaccines.
Famous self-experimentation research includes Barry Mar-
shall’s ingestion of helicobacter culture to prove that the
bacteria cause gastrointestinal disease and Werner Forss-
mann’s insertion of a catheter into his own heart to demon-
strate this procedure could be done safely [1]. Although
self-experimentation has helped to elucidate the aetiology
of treatable diseases and to advance in medical procedures,
some self-experiments led their subjects to permanent dis-
ability and death [2].
Self-experimentation was a common practice in medical
research before the institutionalisation of ethical research
through the Nuremberg Code, the Helsinki Declaration, in-
stitutional review boards and research regulations. Until
the late 20th century, researchers viewed self-experimenta-
tion as an ethical approach to doing science, given the eth-
ical implications of exposing others to the potential neg-
ative effects of untested interventions. Today, this idea
is far from mainstream research ethics. However, based
on the premise that exceptional times demand exceptional
actions, the urgency to find and develop a vaccine for
COVID-19 has fuelled a renewed debate on the ethics of
self-experimentation [3].
In early 2020, a group called Rapid Deployment Vaccine
Collaborative (RaDVac) [4] began the design, production
and self-administration of progressive generations of nasal
inoculations, which could potentially act as a vaccine
against COVID-19. At least 20 scientists and inventors are
participating in this so-called “citizen science” vaccine ini-
tiative and are taking the inoculation, including George
Church and Preston Estep, two renowned researchers at
Harvard University. The RaDVac group is developing its
vaccine without the permission of the US Food and Drugs
Administration (FDA) nor with any ethics board approval,
and they have so far not published any results showing
that their vaccine leads to the creation of antibodies against
the virus in humans [5]. Other self-experiments for a
COVID-19 vaccine include scientists working in China,
Germany, Russia and the United States [6].
Some authors have argued that scientists’ enthusiasm with
their own experiments may get in the way of good judge-
ment, and that modern regulatory and ethics review sys-
tems provide a better route to determine when, how and
who should participate in an experiment [7]. Although
this argument opposes some of the recent self-experiments
that have been carried out to find a COVID-19 vaccine,
it is not necessarily in conflict with self-experimentation
per se. Scientists could in principle request approval from
their ethics boards to conduct self-experiments, although
it is doubtful they would be prepared to grant it. Even
though the Nuremberg Code authorised self-experimenta-
tion, most subsequent ethics regulations (e.g., the Declara-
tion of Helsinki) do not address the matter directly, leaving
self-experimenters in a grey zone. Given the resurgence of
this type of initiative in the unprecedented situation that we
are in, we think it is worthwhile to ask: Is self-experimen-
tation ethical in a pandemic, and if so, under what condi-
tions?
An important argument against self-experimentation is its
potential risk of exerting undue pressure on research team
members. Think of a team of senior and junior scientists,
in which senior scientists suggest embarking on self-exper-
imentation. Junior members may not wish to participate as
study subjects in the experiment, but fear that by refusing
to participate they might not be invited to future projects.
To overcome this potential pressure, junior team members
may be excluded from participating as research subjects
when their employers or supervisors lead the study. This
would still allow junior researchers to self-experiment on
studies led by themselves.
In the context of vaccine development, self-experimenta-
tion may be harmful in at least three ways. First, it may
cause dangerous immune reactions. However, as a counter-
argument, all new vaccines are potentially risky, and if the
risks have been properly assessed, there are no reasons to
believe that self-experimenters would be exposed to high-
er risks compared with participants of standard vaccine tri-
als. Second, self-experimentation in vaccine development
could pave the way for quackery, where experimenters
may be tempted to sell or give away products they found
to work well on themselves but have not passed standard
testing. Drug regulation would typically take care of this
issue. Third, potential vaccines developed through self-
experimentation may give a false sense of protection to
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users outside the research community. Recently, a profes-
sor in Brazil communicated the RaDVaC group his inten-
tion to produce their nasal inoculation against COVID-19
in his laboratory and to distribute it for free [6]. Given the
absence of scientific evidence regarding the effectiveness
and safety of this product, distributing it among the public
could create a false sense of protection (as users may relax
protective measures) and provoke direct negative health ef-
fects. This case illustrates the blurry boundaries between
self-experimental studies and early use of new vaccines
that have not undergone standard testing.
Arguments raised to support self-experimentation include
its potential to benefit humanity, to foster scientists’ educa-
tion, and to promote a culture of responsibility and public
trust. Self-experimenters have played a crucial role in vac-
cine research by taking the initial risk of injecting them-
selves as a quick and cheap way to get new data, making
it safer for others to follow [2]. Another reason to sup-
port self-experimentation is its potential as an education-
al method. As study subjects, researchers can obtain valu-
able information about their work and this experience may
increase the quality of their investigations [8]. Moreover,
scientists who participate as study subjects express soli-
darity towards their study participants, fostering a “culture
of responsibility” in which researchers understand and em-
brace ethical requirements [8]. Relatedly, self-experimen-
tation is also a way to earn public trust in research because
it demonstrates the researcher’s genuine commitment to
the quest for knowledge [8].
In the times of the coronavirus pandemic, the timely de-
velopment of a vaccine has an immense potential to im-
prove global health. In this context, self-experimentation
may be a valuable means to achieve faster pre-research
results, which, if promising, could undergo standard vac-
cine trials. Moreover, considering that vaccine hesitancy
has been identified as one of the world’s top global health
threats by the World Health Organization [9], self-experi-
mentation in the development of a COVID-19 vaccine may
increase public trust in vaccination.
However, self-experiments may also backfire on public
trust if done in risky ways. If self-experimentation is con-
ducted without ethical approval, if researchers are put un-
der undue pressure to try vaccines in themselves, or if
self-experimenters start distributing vaccines that have not
undergone standard trials, the public may lose confidence
in science. The potential role of self-experimentation in the
search for a vaccine is in urgent need of further clarifica-
tion.
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